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Announcements Fellowships, Grants, & Awards
Global Research Initiative Program,
Behavioral/Social Sciences (R01) 
This program is intended to promote productive
development of foreign investigators from low- to
middle-income countries, trained in the United
States or in their home countries through specific
Fogarty International Center D43 or U2R training
programs, to independent researcher in their home
countries or other low- or middle-income countries.
This program will dovetail with several specific
research training mechanisms, including training in
the NIH Intramural Visiting Fellows Program, the
Fogarty International Center research training pro-
grams (D43 or U2R), the NIDA INVEST, or
Humphrey Fellowships, NIEHS junior scientist
programs, and the Human Frontier Science
Program, as part of a broader program to enhance
the scientiﬁc research infrastructure in low- to mid-
dle-income countries, to stimulate research on a
wide variety of high-priority health-related issues of
importance in those countries, and to advance NIH
efforts to address health issues of global import.
The speciﬁc goal of this initiative is to provide
funding opportunities for the increasing pool of
foreign social and behavioral scientists, clinical
investigators, nurses, and other health profession-
als, on their return to their home countries, with
state-of-the-art knowledge of research methods to
advance the critical issues in global health through
social and behavioral sciences research.
After their term of research training, low- to
middle-income country participants supported by
this announcement are expected to continue inde-
pendent and productive scientific careers, includ-
ing providing expert training and consultation to
others, and/or research on behavioral and/or social
science issues within their home institutions.
This announcement contributes to the FIC
mission and the broad NIH initiative to reduce
health disparities among nations by strengthening
research infrastructure in low- to middle-income
countries, particularly those with the least eco-
nomic resources. It also provides the opportunity
for recently trained international health and health
care researchers to continue their projects after
returning home.
Definitions of “behavioral” and “social”: For
the purposes of this initiative, the term “behav-
ioral” refers to overt actions; to underlying psycho-
logical processes such as cognitions, emotion,
temperament, and motivation; and to biobehav-
ioral interactions. The term “social” encompasses
sociocultural, socioeconomic, and sociodemo-
graphic status; to biosocial interactions; and to the
various levels of social context from small groups to
complex cultural systems and societal inﬂuences.
The core areas of behavioral and social sciences
research are those that have a major and explicit
focus on the understanding of behavior and social
processes, or on the use of these processes to predict
or inﬂuence health outcomes or health risk factors.
These core areas of research are divided into basic
(or fundamental) research and clinical research. 
As part of its global health initiative under the
Department of Health and Human Services
(DHHS), the Fogarty International Center (FIC), in
partnership with the National Eye Institute (NEI);
the National Institute on Drug Abuse (NIDA); the
National Institute of Environmental Health Sciences
(NIEHS); the National Institute of General Medical
Sciences (NIGMS); all of the National Institutes of
Health (NIH), and the Office of Behavioral and
Social Sciences Research (OBSSR), the Office of
Dietary Supplements (ODS), and the Office of
Research on Women’s Health (ORWH), all of the
Office of the Director (OD) of the NIH, invites
applications from current and former NIH-sup-
ported foreign research trainees to compete for funds
that will support their research efforts upon return to
their home countries. To be eligible, foreign scien-
tists must meet at least one of the following criteria:
1) at least 2 years of research training experience
under an FIC-supported training grant (classiﬁed by
the D43 and U2R mechanisms); 2) 1 year of such
D43 or U2R training experience coupled with 1 year
of signiﬁcant, well-documented, mentored research
experience (e.g., through an NIH research award
such as the NIAID Small Research (R03) Grant
(IRID-NIAID) program); 3) 1 year of the NIDA
INVEST or Humphrey Fellowship (http://www.
drugabuse.gov/International/HHHRF.html) plus at
least one additional year of significant, well-docu-
mented, mentored research; 4) at least 2 years of
research training experience through the NIH
Intramural Visiting Fellows Program; 5) 1 year of
training through an F05 international fellowship
program and 1 subsequent year of mentored
research; 6) recipients of Long-Term Fellowship
awards through the Human Frontier Science
Program, who come from low- and middle-income
countries, and who have spent at least 2 years in
research training; 7) at least 1 year of training in the
United States and one additional year of signiﬁcant,
well-documented, mentored research, in the United
States  or abroad, leading to a completed master’s
degree or doctoral degree, at least partially funded
through a Fogarty International Center research
training program, with preapproval by the program
director; 8) foreign trainee researchers from low- or
middle-income countries trained under NIEHS R01,
R37, and P01 programs, as described at http://www.
niehs.nihgov/dert/programs/capacity.htm.
All such training and research must either have
been done in the United States or have been part of
in-country research associated with a degree or men-
tored postdoctoral research under the D43 or U2R
award mechanism and completed within 4 years of
the receipt date of this announcement.
Candidates who are more than 5 years beyond
their training, but who have interrupted their
careers because of illness or family commitments,
may also apply. They must clearly explain the
interrupted hiatus and must clearly demonstrate
the potential for productive independent research.
Current NIH Visiting Fellows are encouraged
to apply in a timely fashion, i.e., as they begin their
preparation to return home. They, as all applicants,
may apply within 4 years of completing training.
Through various programs, the NIH has made
a signiﬁcant investment in training biomedical and
behavioral researchers. For example, the NIH
Visiting Fellows Program currently hosts more
than 1,600 junior scientists from almost 100 coun-
tries for periods of 1–5 years. In addition, the NIH
D43 research training and capacity building and
the U2R cooperative agreement grant mechanisms
allow hundreds of foreign researchers to receive
training at prominent institutions in both the
United States and their home countries in a range
of biomedical and behavioral research areas critical
to advancing global health. In summary, training
supported by NIH is critical to these young inves-
tigators as they develop independent research
careers. 
As junior scientists complete training programs
in the United States and in their home institutions
under FIC D43 or U2R programs, many ﬁnd it dif-
ﬁcult to secure the support needed to continue their
research projects and careers as independent
researchers in their home countries. This Global
Research Initiative Program (GRIP) provides the
opportunity for junior foreign scientists to compete
for such funds through a peer-reviewed process.
This is a critical adjunct in the continuation of
promising independent research careers that will be
of beneﬁt to the investigators’ home countries and
the world at large. Women and underrepresented
minority scientists in their countries are especially
encouraged to apply for these re-entry grants.
Project proposals should be geared toward the
research interests of the applicant and the focus on
high-priority health and health care problems in the
investigator’s home country that also carry global
importance, and are of interest to the collaborating
NIH Institutes, Centers, and Ofﬁces (ICs) listed on
the ﬁrst page of this announcement, as well.
It is expected that research topics will vary.
Speciﬁc research interests of partnering ICs can be
found on the ICs’ websites, as listed in the begin-
ning of this announcement. Research related to
women’s health, including studies of gender differ-
ences in disease onset and progression, identiﬁcation
of behavioral strategies that are effective in encourag-
ing healthy lifestyles in young girls and women, as
well as behavioral strategies to encourage prevention
of diseases such as STDs and diseases with higher
prevalence among women (including infectious dis-
eases, lupus, multiple sclerosis, and depression), are
particularly encouraged. Research on healthy out-
comes of pregnancy and child survival, and popula-
tion research as associated with both behavioral and
social, and economic research is encouraged.
Research related to the health effects of human
exposures to environmental agents is encouraged.
Research focused on behavioral and social determi-
nants and their effects on health is also encouraged.
All research must be performed in accordance with
NIH and U.S. government regulations regarding the
responsible conduct of research. This announcement
precludes the support of research involving enroll-
ment in pilot studies for clinical trials, or the actual
support of clinical trials since the resources and
infrastructure to support and oversee such trials gen-
erally exceed the resources available under this award
mechanism. Applicants are encouraged to visit the
website of the Ofﬁce of Human Research Protection
(OHRP) (http://www.hhs.gov/ohrp/) that outlines
these regulations. For information on animal protec-
tion in research, see http://grants.nih.gov/grants/
olaw/olaw.htm.
This announcement contributes to the FIC mis-
sion and to the broad NIH initiative to reduce the
health disparities among nations by strengthening
research infrastructure in developing countries, partic-
ularly those with the least economic resources.
Additionally, it provides the opportunity for recently
trained international health and health care researchers
to continue their projects after returning home. 
Evaluation of the program will occur on an ongo-
ing basis. Because this is a program to move research
trainees to the status of independent investigator, there
are several outcomes to be measured: 1) development
of the laboratory capabilities or research projects;
2) training of other potential researchers; 3) publica-
tions in international peer-reviewed journals, as well as
local journals; 4) participation in workshops, seminars,and international conferences; 5) collaborations with
past mentors, as well as other U.S., international, or
local researchers; and 6) attraction of funding from
other sources.
As part of its assessment of the impact and sci-
entific productivity of this program, FIC plans to
track researchers and their trainees for at least
10 years after beginning their independent
research. Evaluation may focus on the success of
researchers (as measured by the number and qual-
ity of publications, presentations, courses, awards,
subsequent employment, etc.), their sustained
commitment to research careers, their ability to
attract funding for their work, their contributions
to future international collaborations, their influ-
ence on the development of scientific research in
their countries, and their ability to act as consul-
tants, teachers, and role models to other local
investigators and further disseminate the lessons
learned. Applicants should describe potential met-
rics that would indicate the success of the individ-
ual researcher and the success in capacity building
at the home institution, including the impact of
the program on research at the institution in the
home countries of researchers and their trainees. 
This Funding Opportunity Announcement
(FOA) will use the NIH Research Project Grant
(R01) award mechanism.  
The applicant will be solely responsible for plan-
ning, directing, and executing the proposed project. 
This FOA uses “Just-in-Time” information
concepts. It also uses the nonmodular budget for-
mats (see http://grants.nih.gov/grants/funding/
modular/modular.htm).
All foreign applicants must complete and submit
budget requests using the Research & Related Budget
component found in the application package for this
FOA. See NOT-OD-06-096, 23 August 2006.  
This award is nonrenewable. An investigator
cannot receive a second award in this program. 
Applicants must download the SF424 (R&R)
application forms and the SF424 (R&R) Application
Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package directly
attached to a specific FOA can be used. You will
not be able to use any other SF424 (R&R) forms
(e.g., sample forms, forms from another FOA),
although some of the "Attachment" files may be
useable for more than one FOA.
For further assistance, contact GrantsInfo,
301-435-0714, (telecommunications for the hear-
ing impaired: TTY 301-451-0088), or by e-mail:
GrantsInfo@nih.gov.
The letter of intent dates for this PAR are
21 August 2007, 2008, and 2009 with the applica-
tion receipt dates 21 September 2007, 22 September
2008, 21 September 2009. 
The complete version of this PAR is available at
http//www.grants/guide/pa-ﬁles/PAR-07-328.html.
The complete list of agency contacts is avail-
able at http://grants.nih.gov/grants/guide/pa-
ﬁles/PAR-07-328.html. Reference: PAR-07-328.
Non-Biodefense Emerging Infectious Diseases
Research Opportunities (R01)
The goal of this FOA is to increase understanding
of the transition of microbes from a nonpathogenic
state to a state pathogenic for humans. 
One area of interest is to promote research in
emerging zoonotic viruses, which will provide pre-
dictive tools to anticipate the emergence of new viral
pathogens. Many emerging viral diseases are
zoonotic in origin; it is estimated that approximately
62% of human infectious diseases are zoonotic and
an estimated 70% of newly emerging diseases are
zoonotic in origin. The recent emergence and trans-
mission to humans of SARS CoV from civet cats
and deadly avian inﬂuenza clearly demonstrate that
emerging zoonotic viral diseases are a serious public
health problem that needs to be understood fully.
Although it is clear that one of the principle mecha-
nisms involved in the emergence of new viral dis-
eases is a change in the host range, there are many
gaps in our knowledge about the mechanism(s)
involved and how zoonotic viruses establish them-
selves in humans. An understanding of these
processes will be necessary to anticipate and prepare
for the emergence of new viruses in humans. 
Another area of interest is the study of human
bacterial pathogens that exist in colonizing, rather
than infective states. In colonizing states these
human pathogens are in consortia with other
microbes, such as when Staphylococcus aureus colo-
nizes skin or mucosal tissues without causing disease
or when Clostridium difﬁcile colonizes the gut with-
out causing illness or when Neisseria meningitidis is
in the nasopharyngeal tract without causing disease.
Little if anything is known about the full comple-
ment of microbes present or the structure and func-
tioning of the microbial consortium. It is important
to know what microbes are present, in what propor-
tions, and how the consortium functions metaboli-
cally. Clearly, the consortium has an interface with
the host and this may play a critical role in deter-
mining if the microbes remain as colonizers or cause
disease. There are several potential colonizing niches
in the body for which this concept applies such as
skin, gastrointestinal, nasopharyngeal, and geni-
tourinary tracts. Metagenomics as well as micro-
scopic techniques that allow for visualization of the
physical structure of the microbial consortium are
experimental approaches of interest. 
Two recent workshops (Emergence of New
Epidemic Viruses through Host Switching and
Workshop on Basic Bacterial Research), sponsored in
part or in whole by NIAID, resulted in reports that
identify areas that are in need of additional research.
This FOA is intended to address some of these areas. 
Relevant topics of interest include, but are not
limited to: 1) Studies on the natural history of emerg-
ing viruses, viral reservoirs, natural means of transmis-
sion, variation and pathogenesis (excluding HIV and
viruses among the NIAID Category A, B & C
Priority Pathogens); 2) Studies on the factors that
control host–host transmission: pathogenesis studies
focused on the development of emerging human
pathogenic viruses; viral and host control of viral
shedding and infection; 3) Studies on the evolution-
ary events surrounding the transfer of viruses to new
hosts, sequence analysis of viruses before and after the
transfer, emergence of variants in the donor host, the
transfer event, and post-transfer adaptation;
4) Characterizing human microbial pathogens as they
live in nonpathogenic microbial consortia. Research
should focus on describing what microbes are present
in the consortia, and the metabolism of the consortia,
their physical structure and interaction with the envi-
ronment. Examples of possible experimental
approaches include metagenomics, single-cell analysis,
and microscopy; 5) Understanding the relationship
between microbiota and human health as it inﬂuences
emergence of disease or new human pathogens;
6) Identifying signals and systems in bacterial
communication relevant to the development of
pathogenesis or emergence of new human pathogens;
7) Determining whether and how microbiota and
human pathogens communicate with host cells and
respond to the mammalian immune system;
8) Developing strategies to manipulate chemical sig-
naling of human pathogens within the microbiota.
This FOA will not support studies on HIV or
pathogens among the NIAID Category A, B & C
Priority Pathogens.
This Funding Opportunity Announcement
(FOA) will use the NIH Research Project Grant
(R01) award mechanism. 
The applicant will be solely responsible for plan-
ning, directing, and executing the proposed project. 
This FOA uses “Just-in-Time” information
concepts. It also uses the modular as well as the
nonmodular budget formats (see http://grants.nih.
gov/grants/funding/modular/modular.htm).
Speciﬁcally, if you are a U.S. organization and
are submitting an application with direct costs in
each year of $250,000 or less (excluding consor-
tium Facilities and Administrative [F&A] costs),
use the PHS398 Modular Budget component pro-
vided in the SF424 (R&R) Application Package
and SF424 (R&R) Application Guide (see speciﬁ-
cally Section 5.4, “Modular Budget Component,”
of the Application Guide). 
U.S. applicants requesting more than
$250,000 in annual direct costs and all foreign
applicants must complete and submit budget
requests using the Research & Related Budget com-
ponent found in the application package for this
FOA. See NOT-OD-06-096, 23 August 2006. 
Applicants must download the SF424 (R&R)
application forms and the SF424 (R&R) Application
Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package directly
attached to a specific FOA can be used. You will
not be able to use any other SF424 (R&R) forms
(e.g., sample forms, forms from another FOA),
although some of the "Attachment" files may be
useable for more than one FOA.
For further assistance, contact GrantsInfo,
301-435-0714, (telecommunications for the hear-
ing impaired: TTY 301-451-0088), or by e-mail:
GrantsInfo@nih.gov.
The application submission dates of this PA
are available at http://grants1.nih.gov/grants/fund-
ing/submissionschedule.htm. 
The complete version of this PA is available at
http://grants.nih.gov/grants/guide/pa-files/PA-07-
246.html.
Contacts: N. Kent Peters, Division of
Microbiology and Infectious Diseases, National
Institute for Allergy and Infectious Diseases, Room
4068, MSC-6603, 6610 Rockledge Drive,
Bethesda, MD 20892-6603 USA, 301-496-7728,
fax: 301-402-2508, e-mail: petersn@niaid.nih.gov;
Eun-Chung Park, Division of Microbiology and
Infectious Diseases, National Institute for Allergy
and Infectious Diseases, Room 4103, MSC-6604,
6610 Rockledge Drive, Bethesda, MD 20892-
6604 USA, 301-402-0071, fax: 301-402-2508, e-
mail: epark@niaid.nih.gov; Irene Anne Eckstrand,
National Institute of General Medical Sciences, 45
Center Drive, Room 2AS.25K, MSC 6200,
Bethesda, MD 20892 USA, 301-594-0943, e-mail:
eckstrai@mail.nih.gov. Reference: PA-07-246.
Fellowships, Grants, & Awards
Environmental Health Perspectives • VOLUME 115 | NUMBER 5 | May 2007 A 267